Skip to main content
TipRanks
Go Ultimate75% OFF

Sarita Kapila Profile - Morgan Stanley Analyst

18 Followers

Sarita Kapila's Stock Coverage

GSK
GlaxoSmithKline
Aug 25, 2026SELLReiterated1,900.00 p9Ratings13%-20.71%
SAN
Sanofi
Aug 11, 2026HOLDReiterated€82.002Ratings――
RHHBY
Roche Holding
Aug 07, 2026BUYUpgraded$63.003Ratings33%-21.00%
AZN
AstraZeneca
Jul 16, 2026BUYReiterated15,300.00 p12Ratings67%+8.49%
SNY
Sanofi
Jul 08, 2026HOLDReiterated$49.004Ratings0%-1.50%
ROP
Roche Holding AG
Apr 24, 2026HOLDUpgradedCHF295.0010Ratings40%-16.20%
SOBI
Swedish Orphan Biovitrum AB
May 04, 2023HOLDReiteratedkr257.882Ratings――
GRFS
Grifols SA
Feb 08, 2023BUYReiterated$17.872Ratings50%-2.20%
GRF
Grifols
Feb 08, 2023BUYReiterated€16.006Ratings50%-6.00%

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Sarita Kapila activity FAQ

What is the performance of Sarita Kapila's recommendations?
The percentage of profitable recommendations made by Sarita Kapila is 45.71%, and the average return per transaction is -4.40%.
What stocks does Sarita Kapila cover?
Sarita Kapila mostly covers GlaxoSmithKline, Sanofi, Roche Holding stocks.
What was Sarita Kapila's most profitable rating?
Sarita Kapila’s most profitable rating was a buy on BE:UCB stock on Jun 23, 2025. The return on the trade was 53.60%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here